Authors
Loading...
Two cohort studies demonstrate high feasibility and low missingness for PROMIS measures in pediatric oncology, indicating their clinical utility across treatment and survivorship.
Menard et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: